Clare Jolly

Great Ormond Street Hospital — United Kingdom

Immunology and Microbiology · Life Sciences

32h-index5.3kcitations85works12.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

HIV Research and Treatment(38), Immune Cell Function and Interaction(23), SARS-CoV-2 and COVID-19 Research(19), T-cell and B-cell Immunology(18), COVID-19 Clinical Research Studies(12)

Publications85 total

Composite Wilms Tumor and Renal Cell Carcinoma
The American Journal of Surgical Pathology·2026
Human guanylate-binding protein (GBP) 1 inhibits replication of severe acute respiratory syndrome coronavirus 2
Journal of Virology·2025Open Access
Signatures of omicron-like adaptation in early SARS-CoV-2 variants and chronic infection
Cell Reports·2025· 1 citedOpen Access
Ex vivo T-lymphopoiesis assays assisting corrective treatment choice for genetically undefined T-lymphocytopenia
Universität Zürich, ZORA·2025Open Access
HIV-1 Gag-protease-driven replicative capacity influences T-cell metabolism, cytokine induction, and viral cell-to-cell spread
mBio·2025Open Access
Macrocycle-based PROTACs selectively degrade cyclophilin A and inhibit HIV-1 and HCV
Nature Communications·2025· 17 citedOpen Access
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Nature Microbiology·2024· 71 citedOpen Access
SARS-CoV-2 variants evolve convergent strategies to remodel the host response
Cell·2023· 109 citedOpen Access
Disease-attenuated pneumococcal biosynthesis gene mutants invade the mucosal epithelium and induce innate immunity
2023· 1 citedOpen Access
Synthetic PROTACs based on a depsipeptide macrocycle selectively degrade cyclophilin A and inhibit HIV-1
2023· 2 citedOpen Access
SARS-CoV-2 evolution influences GBP and IFITM sensitivity
Proceedings of the National Academy of Sciences·2023· 46 citedOpen Access
SARS-CoV-2 Variants Evolve Convergent Strategies to Remodel the Host Response
SSRN Electronic Journal·2023· 12 citedOpen Access
Global landscape of the host response to SARS-CoV-2 variants reveals viral evolutionary trajectories
2022· 13 citedOpen Access
Evolutionary remodelling of N‐terminal domain loops fine‐tunes <scp>SARS‐CoV</scp> ‐2 spike
EMBO Reports·2022· 40 citedOpen Access
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
2022· 16 citedOpen Access
HIV-1 Vpr drives a tissue residency-like phenotype during selective infection of resting memory T cells
Cell Reports·2022· 24 citedOpen Access
Publisher Correction: Evolution of enhanced innate immune evasion by SARS-CoV-2
Nature·2022· 12 citedOpen Access
Local and systemic responses to SARS-CoV-2 infection in children and adults
2022· 1 cited
SARS-CoV-2 Spike evolution influences GBP and IFITM sensitivity
2022· 5 citedOpen Access
Executable network of SARS-CoV-2-host interaction predicts drug combination treatments
npj Digital Medicine·2022· 13 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Ann‐Kathrin Reuschl(17), Greg J. Towers(15), Lucy Thorne(14), Quentin J. Sattentau(12), Matthew V. X. Whelan(10), Lorena Zuliani‐Alvarez(8), Jane Turner(8), Dejan Mesner(7), Mehdi Bouhaddou(6), Roberta Ragazzini(6), Kirsten Obernier(6), Paola Bonfanti(6), Adolfo Garcı́a-Sastre(6), Nevan J. Krogan(6), Margaret Soucheray(5), Romel Rosales(5), Jacqueline M. Fabius(5), Kris M. White(5), Mahdad Noursadeghi(5), Danielle L. Swaney(5)